US 10596275
Virion-derived nanospheres for selective delivery of therapeutic and diagnostic agents to cancer cells
granted A61KA61K38/162A61K45/06
Quick answer
US patent 10596275 (Virion-derived nanospheres for selective delivery of therapeutic and diagnostic agents to cancer cells) held by Aura Biosciences, Inc. expires Mon Mar 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Aura Biosciences, Inc.
- Grant date
- Tue Mar 24 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 30
- CPC classes
- A61K, A61K38/162, A61K45/06, A61K47/6901, A61K47/6929